Science Explorer Back to mapMap
Discussion
Researcher · University of Pittsburgh · United States

Michael T. Lotze

Michael T. Lotze publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers and Immune Cell Function and Interaction.

ORCID 0000-0003-3988-5419 OpenAlex
World rank
#31,945
of 7,710,434 ranked researchers
Rank in United States
#12,104
of 1,627,098
Works
895
Citations
84k
Citations per work
93.3
h-index
135
i10-index 432Top 0.1% in Immunology
Michael T. Lotze

What does Michael T. Lotze research?

Michael T. Lotze's work is mostly in Immunology and Microbiology (30%), Medicine (23%), Biochemistry, Genetics and Molecular Biology (19%).

Life Sciences: 439 works · 49.0% of their workImmunology and Microbiology: 265 works · 29.6% of their workImmunology: 265 works · 29.6% of their workBiochemistry, Genetics and Molecular Biology: 174 works · 19.4% of their workMolecular Biology: 106 works · 11.8% of their workClinical Biochemistry: 37 works · 4.1% of their workCancer Research: 31 works · 3.5% of their workEverything else: 251 works · 28.0% of their workHealth Sciences: 206 works · 23.0% of their workMedicine: 206 works · 23.0% of their workOncology: 163 works · 18.2% of their workEpidemiology: 43 works · 4.8% of their workTHEIR WORKMichael T. Lotze895works
Life Sciences49%Health Sciences23%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology26529.6%
    2. Biochemistry, Genetics and Molecular Biology17419.4%
  2. Everything else25128.0%
    1. Medicine20623.0%
  1. 1Immunology30% of their works
  2. 2Oncology18% of their works
  3. 3Molecular Biology12% of their works
  4. 4Epidemiology5% of their works
  5. 5Clinical Biochemistry4% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Michael T. Lotze's research?

The keywords of their largest research topics: Cancer Immunotherapy, Immunity, Antigen Presentation, Dendritic Cells, Inflammation, Immune Checkpoint Blockade, PD-1 and PD-L1 and Natural Killer Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer Immunotherapy3452 topics
  2. Immunity3132 topics
  3. Antigen Presentation2321 topic
  4. Dendritic Cells2321 topic
  5. Inflammation1722 topics
  6. Immune Checkpoint Blockade1531 topic
  7. PD-1 and PD-L11531 topic
  8. NK Cell Recognition1451 topic
  9. Natural Killer Cells1451 topic
  10. CAR T Cells1131 topic
  11. Chimeric Antigen Receptor1131 topic
  12. Advanced Glycation End Products911 topic
  13. HMGB1911 topic
  14. Autophagy811 topic
  15. Disease811 topic
  16. Foxp3681 topic
  17. TGF-ß681 topic
  18. Gene Therapy631 topic
  19. Viral Vectors631 topic

Where does Michael T. Lotze work?

Michael T. Lotze's main affiliation in the publication record is University of Pittsburgh, United States.

How many publications and citations does Michael T. Lotze have?

OpenAlex counts 895 works and 83,540 citations for Michael T. Lotze, an h-index of 135, ranking #31,945 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Michael T. Lotze. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.